Contact Information
37 Westminster Buildings, Theatre Square,
Nottingham, NG1 6LG
Why Micron Stock Surged After Disappointing Earnings
Micron Technology (NASDAQ: MU) reported over a 50% year-over-year decline in revenue, yet why have investors decided to buy up the stock? Check out the
A Bull Market Is Coming: 1 AI Stock That Could Jump 93%, According to Wall Street
This is turning out to be a solid year for technology stocks following last year’s forgettable performance — as evidenced by the 21.7% gains clocked
PFE vs. ABBV: Which Pharmaceutical Stock is Better?
In this piece, I used TipRanks’ comparison tool to evaluate two pharmaceutical stocks, Pfizer Inc. (NYSE:PFE) and AbbVie Inc. (NYSE:ABBV), to determine which is better.
European stock futures flat; Eurozone inflation release looms large By Investing.com
© Reuters. By Peter Nurse Investing.com – European stock markets are expected to open largely unchanged Friday, with investors digesting mixed Chinese activity ahead of
Higher Open Called For China Stock Market
(RTTNews) – The China stock market on Thursday ended the four-day losing streak in which it had fallen more than 45 points or 1.5 percent.
Why Amazon Stock Shot Nearly 2% Higher Today
What happened Amazon (NASDAQ: AMZN) stock was an outperformer on Thursday, rising almost 2% higher against the S&P 500 index’s 0.6% gain. This was due
This Stock Has A 3.65% Yield, Sells For Less Than Book, and Insiders Have Been Buying
In this series, we look through the most recent Dividend Channel ”DividendRank” report, and then we cherry pick only those companies that have experienced insider
Why Intel Stock Thumped the Market on Thursday
What happened Artificial intelligence (AI) is all the rage in tech investor circles these days, so companies touting their efforts in this sphere have often
Exclusive-Massachusetts regulator probes First Republic insiders’ stock sales By Reuters
© Reuters. FILE PHOTO: A person walks past a First Republic Bank branch in Midtown Manhattan in New York City, New York, U.S., March 13,
2 Reasons to Sell Editas Medicine Stock and 1 Reason to Buy It
There’s a lot of excitement around the potential for gene-editing stocks because their therapies have the potential to not only treat diseases, but cure them.